Journal Information
Most Often Read
29964
Covid-19: Round and oval areas of ground-glass opacityW. Schmitt, E. Marchiori
29964
Open access
Available online 26 April 2020
25700
New drugs and perspectives for new anti-tuberculosis regimensS. Tiberi, M. Muñoz-Torrico, R. Duarte, M. Dalcolmo, L. D’Ambrosio, G.-B. Migliori
Pulmonol. 2018;24:86-98
25700
Open access
18523
Diaphragmatic dysfunctionJ. Ricoy, N. Rodríguez-Núñez, J.M. Álvarez-Dobaño, M.E. Toubes, V. Riveiro, L. Valdés
Pulmonol. 2019;25:223-35
18523
Open access
13008
Tuberculosis, social determinants and co-morbidities (including HIV)R. Duarte, K. Lönnroth, C. Carvalho, F. Lima, A.C.C. Carvalho, M. Muñoz-Torrico, R. Centis
Pulmonol. 2018;24:115-9
13008
Open access
12144
Medical masks and Respirators for the Protection of Healthcare Workers from SARS-CoV-2 and other virusesMariachiara Ippolito, Filippo Vitale, Giuseppe Accurso, Pasquale Iozzo, Cesare Gregoretti, Antonino Giarratano, Andrea Cortegiani
Pulmonol. 2020;26:204-12
12144
Open access
12056
COPD exacerbations: management and hospital dischargeA.J. Reis, C. Alves, S. Furtado, J. Ferreira, M. Drummond, C. Robalo-Cordeiro
Pulmonol. 2018;24:345-50
12056
Open access
11657
Tuberculosis and gender – Factors influencing the risk of tuberculosis among men and women by age groupR. Marçôa, A.I. Ribeiro, I. Zão, R. Duarte
Pulmonol. 2018;24:199-202
11657
Open access
11111
COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problemsJ.C. Winck, N. Ambrosino
Pulmonol. 2020;26:213-20
11111
Open access
10623
Identification and assessment of COPD exacerbationsA.S. Oliveira, J. Munhá, A. Bugalho, M. Guimarães, G. Reis, A. Marques
Pulmonol. 2018;24:42-7
10623
Open access
9752
COPD and Cardiovascular DiseaseS. André, B. Conde, E. Fragoso, J.P. Boléo-Tomé, V. Areias, J. Cardoso
Pulmonol. 2019;25:168-76
9752
Open access